Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma
December 07, 2021 at 10:31 AM EST
Vir Biotechnology and GlaxoSmithKline’s COVID-19 antibody treatment worked against omicron in a laboratory study.
